Company · CIK 1776612
Akston Biosciences Corp
| CIK | 1776612 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | none on EDGAR |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-290778 | 2025-10-08 | 2026-05-04 | 7 |
Filings
8| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-05-04 | S-1/AAmendment | 333-290778 | 0001104659-26-054475 |
| 2026-04-10 | S-1/AAmendment | 333-290778 | 0001104659-26-041980 |
| 2026-02-18 | S-1/AAmendment | 333-290778 | 0001104659-26-017032 |
| 2026-01-15 | S-1/AAmendment | 333-290778 | 0001104659-26-004158 |
| 2025-12-08 | S-1/AAmendment | 333-290778 | 0001104659-25-119211 |
| 2025-11-17 | S-1/AAmendment | 333-290778 | 0001104659-25-112780 |
| 2025-10-08 | S-1Registration filed | 333-290778 | 0001104659-25-097958 |
| 2025-07-25 | DRSDraft made public | 377-08261 | 0001104659-25-070885 |